Last reviewed · How we verify

NCT05445362

Efficacy of Diode Laser in Maturogenesis of Immature Teeth With Necrotic Pulps

Completed NA Last updated 25 August 2022
What this trial tests

NA trial testing Diode laser disinfection in Effects of the Elements in 39 participants. Completed in 26 February 2021.

Timeline
1 February 2019
Primary endpoint
30 August 2020
26 February 2021

Quick facts

Lead sponsorReham Hassan
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment39
Start date1 February 2019
Primary completion30 August 2020
Estimated completion26 February 2021
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Reham Hassan — full company profile →

Who can join

Adults 8 to 16, any sex, with Effects of the Elements. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Recruited patients with immature permanent maxillary anterior teeth with non-vital pulp, and periapical radiolucency, age ranging from 8 to16 years old were randomly allocated into three groups (n=13): Group I, disinfected using the triple antibiotic paste, Group II, disinfection was done using diode laser, and Group III, were disinfected using the triple antibiotic paste, diode laser was used for biostimulation. All groups were evaluated for the increase in root length and thickness and decrease in apical diameter at baseline, 3, 6, 9, and 12 months after treatment

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Diode laser disinfection

Trials testing the same drug.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05445362.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing